Qiagen N.V. (BIT:1QGEN)
36.44
+0.90 (2.53%)
At close: Apr 11, 2025, 5:30 PM CET
Qiagen Revenue
In the year 2024, Qiagen had annual revenue of $1.98B USD with 0.66% growth. Qiagen had revenue of $521.20M in the quarter ending December 31, 2024, with 2.36% growth.
Revenue
$1.98B
Revenue Growth
+0.66%
P/S Ratio
4.05
Revenue / Employee
$366.61K
Employees
5,396
Market Cap
7.74B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Recordati Industria Chimica e Farmaceutica | 2.34B |
DiaSorin | 1.19B |
Amplifon | 2.41B |
Philogen | 77.65M |
EL.En. | 565.85M |
Pharmanutra | 116.15M |
Garofalo Health Care | 467.77M |
Safilo Group | 993.22M |